Seasonal influenza vaccination in Europe: country data now available
Country profiles on influenza vaccination activity, providing data collected as part of the VENICE III project, are now available.
Country profiles providing data on influenza vaccination activity are now available. The profiles are based on the data used for the seasonal influenza vaccination in Europe report by ECDC and the Vaccine European New Integrated Collaboration Effort III (VENICE III) published earlier this year. These profiles provide a range of data, including to which groups influenza vaccination is recommended, how vaccination coverage is monitored and how the vaccine is paid for.
The reports show which population groups national health authorities target with their vaccination campaigns, and which methods are used to reach their target audiences. All countries recommend vaccination for older people, typically considered to be above 65. Campaigns commonly take place through traditional media, although a range of other methods are also used.
Vaccination coverage rates are also displayed for the five seasons up to and including the 2012–13 season. The data shows that the majority of countries were likely to miss the 2014–15 EU target of 75% vaccination coverage rate for target groups.
Vaccination is still the best way to protect against influenza, and the vaccine needs to be given each year.
The publication of these profiles coincides with the start of the 2015–16 reporting season. During the season, weekly updates of the Flu News Europe website will provide useful information on the intensity and severity of this influenza season across the whole of the EU and the wider WHO European Region.
Flu Awareness Week, 5-9 October 2020
5 Oct 2020 to 9 Oct 2020 - The Flu Awareness Week is marked across the WHO European Region every year in October. It aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.
Looking at newer enhanced seasonal influenza vaccines: a systematic review of efficacy, effectiveness and safety
5 Oct 2020 - Based on a systematic literature review, ECDC assessed the efficacy, effectiveness and safety of newer and enhanced inactivated seasonal influenza (flu) vaccines among those 18 years or older. These assessed are MF59® adjuvanted, cell-based, high-dose, and recombinant haemagglutinin influenza vaccines.